Study of soft tissue sarcoma clinical trial participation
Part of Cancer clinical trials.
This study looks at how people with soft tissue sarcoma take part in clinical trials. By joining, you help researchers learn more about trial participation, which may lead to better access to new treatments for others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with soft tissue sarcoma.
- You are 18 years old or older.
- You can understand and sign a consent form agreeing to take part.
- You are willing to follow the study schedule and attend all required visits.
- If you are a woman who could become pregnant, you must have a negative pregnancy test and not be nursing.
- You do not have other serious or unstable medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune system “fingerprints” using tumor tissue from people with rare soft tissue sarcoma. It may help researchers understand what drives these cancers and guide future treatments.
This trial tests whether a medicine injected directly into a tumor can shrink or control advanced soft tissue sarcoma. It mainly looks for people whose tumors can be safely injected with a hand exam or ultrasound.
This Phase 2 trial looks at how two test approaches (an MRI-based scan and blood tests) work in people with a larger, grade 2 or 3 soft tissue sarcoma. It may help researchers learn better ways to measure the disease and guide care.
This trial studies whether adding an exercise program helps people with soft tissue sarcoma in an arm or leg during a planned treatment course. The treatment they look at is radiation before surgery, then surgery to remove the tumor, and they want to see how exercise affects outcomes and recovery.
This study looks at how people with chondrosarcoma, a rare type of bone cancer, take part in clinical trials. It aims to understand what helps or hinders participation, which could improve future trials.
This study looks at how people with rhabdomyosarcoma engage with clinical trials, with the goal of improving future trial designs. It does not test a new treatment but collects information that could help improve care for people with this cancer.
Hear when a new Soft Tissue Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.